A-kinase-anchoring Protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy

Molecular and Cellular Biology

Volumn 33, Issue 1, 2013, Pages 14-27

  del Vescovo, Cosmo Damiano ^a,b   Cotecchia, Susanna ^a,b   Diviani, Dario ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN LBC PROTEIN COMPLEX; I KAPPA B KINASE BETA; INTERLEUKIN 6; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE MYOCYTE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; ANIMALS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; HYPERTROPHY; I-KAPPA B KINASE; INTERLEUKIN-6; MICE; MUTATION; MYOCYTES, CARDIAC; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECOMBINANT PROTEINS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 84871910829     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00887-12     Document Type: Article

References (41)

1. Hill JA, Olson EN. 2008. Cardiac plasticity. N. Engl. J. Med. 358:1370-1380.
2. Frey N, Katus HA, Olson EN, Hill JA. 2004. Hypertrophy of the heart: a new therapeutic target? Circulation 109:1580-1589.
3. Towbin JA, Bowles NE. 2002. The failing heart. Nature 415:227-233.
4. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RJ. 1994. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 91:10109-10113.
5. O'Connell TD, Ishizaka S, Nakamura A, Swigart PM, Rodrigo MC, Simpson GL, Cotecchia S, Rokosh DG, Grossman W, Foster E, Simpson PC. 2003. The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Investig. 111:1783-1791.
6. Pare GC, Bauman AL, McHenry M, Michel JJ, Dodge-Kafka KL, Kapiloff MS. 2005. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J. Cell Sci. 118:5637-5646.
7. Rockman HA, Wachhorst SP, Mao L, Ross J, Jr. 1994. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am. J. Physiol. 266:H2468-H2475.
8. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I. 2004. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat. Cell Biol. 6:499-506.
9. Heineke J, Molkentin JD. 2006. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7:589-600.
10. Hall G, Hasday JD, Rogers TB. 2006. Regulating the regulator: NFkappaB signaling in heart. J. Mol. Cell. Cardiol. 41:580-591.
11. Purcell NH, Molkentin JD. 2003. Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy? Circulation 108:638-640.
12. Hacker H, Karin M. 2006. Regulation and function of IKK and IKKrelated kinases. Sci. STKE 2006:re13. doi:10.1126/stke.3572006re13.
13. Scheidereit C. 2006. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25:6685-6705.
14. Perkins ND. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8:49-62.
15. Cook SA, Novikov MS, Ahn Y, Matsui T, Rosenzweig A. 2003. A20 is dynamically regulated in the heart and inhibits the hypertrophic response. Circulation 108:664-667.
16. Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, El-Jamali A, Dietz R, Scheidereit C, Bergmann MW. 2005. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol- induced cardiac hypertrophy in vivo. Circulation 111:2319-2325.
17. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, Hori M. 2002. Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105:509-515.
18. Kawamura N, Kubota T, Kawano S, Monden Y, Feldman AM, Tsutsui H, Takeshita A, Sunagawa K. 2005. Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNFalpha- induced cardiomyopathy. Cardiovasc. Res. 66:520-529.
19. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. 2001. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 98:6668-6673.
20. Sorriento D, Santulli G, Fusco A, Anastasio A, Trimarco B, Iaccarino G. 2010. Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension 56:696-704.
21. Usui S, Maejima Y, Pain J, Hong C, Cho J, Park JY, Zablocki D, Tian B, Glass DJ, Sadoshima J. 2011. Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB. Circ. Res. 109:161-171.
22. Zelarayan L, Renger A, Noack C, Zafiriou MP, Gehrke C, van der Nagel R, Dietz R, de Windt L, Bergmann MW. 2009. NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc. Res. 84:416-424.
23. Pawson CT, Scott JD. 2010. Signal integration through blending, bolstering and bifurcating of intracellular information. Nat. Struct. Mol. Biol. 17:653-658.
24. Scott JD, Pawson T. 2009. Cell signaling in space and time: where proteins come together and when they're apart. Science 326:1220-1224.
25. Beene DL, Scott JD. 2007. A-kinase anchoring proteins take shape. Curr. Opin. Cell Biol. 19:192-198.
26. Diviani D, Soderling J, Scott JD. 2001. AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation. J. Biol. Chem. 276:44247-44257.
27. Appert-Collin A, Cotecchia S, Nenniger-Tosato M, Pedrazzini T, Diviani D. 2007. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 104:10140-10145.
28. Carnegie GK, Soughayer J, Smith FD, Pedroja BS, Zhang F, Diviani D, Bristow MR, Kunkel MT, Newton AC, Langeberg LK, Scott JD. 2008. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol. Cell 32:169-179.
29. Diviani D, Abuin L, Cotecchia S, Pansier L. 2004. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J. 23:2811-2820.
30. Petitprez S, Zmoos AF, Ogrodnik J, Balse E, Raad N, El-Haou S, Albesa M, Bittihn P, Luther S, Lehnart SE, Hatem SN, Coulombe A, Abriel H. 2011. SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes. Circ. Res. 108:294-304.
31. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
32. Cariolato L, Cavin S, Diviani D. 2011. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in alpha1- adrenergic receptor-induced p38 activation. J. Biol. Chem. 286:7925-7937.
33. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, Metalnikov P, O'Donnell P, Taylor P, Taylor L, Zougman A, Woodgett JR, Langeberg LK, Scott JD, Pawson T. 2004. Proteomic, functional, and domainbased analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 14:1436-1450.
34. Anwar KN, Fazal F, Malik AB, Rahman A. 2004. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J. Immunol. 173:6965-6972.
35. Smith FD, Langeberg LK, Cellurale C, Pawson T, Morrison DK, Davis RJ, Scott JD. 2010. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat. Cell Biol. 12:1242-1249.
36. Zheng Y. 2001. Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 26:724-732.
37. Perez DM, Papay RS, Shi T. 2009. α1-Adrenergic receptor stimulates interleukin-6 expression and secretion through both mRNA stability and transcriptional regulation: Involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Mol. Pharmacol. 76:144-152.
38. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL. 2010. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56:225-231.
39. Liu Q, Chen Y, Auger-Messier M, Molkentin JD. 2012. Interaction between NFκB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ. Res. 110:1077-1086.
40. Carnegie GK, Smith FD, McConnachie G, Langeberg LK, Scott JD. 2004. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol. Cell 15:889-899.
41. Shibolet O, Giallourakis C, Rosenberg I, Mueller T, Xavier RJ, Podolsky DK. 2007. AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling. J. Biol. Chem. 282:35308-35317.